Yang Li | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Yang Li | Medicine | Best Researcher Award

Shanghai East Hospital, Tongji University School of Medicine | China

Dr. Yang Li is a dedicated postdoctoral researcher at Shanghai East Hospital, affiliated with the Tongji University School of Medicine. With a strong background in internal medicine, he has actively contributed to medical research and patient care. His academic journey is marked by significant achievements, and his work continues to impact the field of clinical medicine, particularly in the areas of metabolic disorders and geriatric health.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background

    • Yang Li has a well-structured academic trajectory, progressing from a Bachelor’s degree in Clinical Medicine to a Postdoctoral position at a reputable institution (Shanghai East Hospital, Tongji University School of Medicine).

    • The M.D. in Internal Medicine and a prior Master’s degree provide a solid foundation for research in this field.

  • Impressive Publication Record

    • Multiple first-author publications in well-regarded medical journals, indicating independent research contributions.

    • Publications focus on crucial areas such as metabolic diseases, multimorbidity, and nephroprotection, showcasing a diverse yet specialized research profile.

    • Collaboration with multidisciplinary teams suggests strong teamwork and networking in the research community.

  • Impactful Research Topics

    • The studies address real-world clinical challenges, including lipid metabolism, diabetes, multimorbidity, and nephroprotection, which have significant implications for patient care.

    • The use of large-scale datasets and real-world analysis enhances the credibility and applicability of findings.

  • Consistency and Productivity

    • Continuous output of publications from 2022 to 2025 demonstrates a sustained research commitment.

    • The ability to conduct retrospective cohort studies and cross-sectional analyses highlights strong methodological expertise.

Education 🎓

Yang Li pursued his higher education at Tongji University, where he earned multiple degrees in clinical and internal medicine:

  • M.D. in Internal Medicine (2020-2023)
  • Master’s Degree in Internal Medicine (2017-2019)
  • Bachelor’s Degree in Clinical Medicine (2011-2017) His academic training has equipped him with in-depth knowledge and expertise in diagnosing and treating complex medical conditions.

Experience 🎉

As a postdoctoral researcher at Shanghai East Hospital, Yang Li has been deeply involved in clinical research, focusing on metabolic health, multimorbidity, and geriatric care. His work bridges the gap between clinical practice and research, aiming to improve patient outcomes through evidence-based findings. His experience spans retrospective cohort studies, cross-sectional analyses, and real-world population-based research.

Research Interest On Medicine 🔬

Yang Li’s research interests include:

  • Metabolic Disorders & Insulin Resistance
  • Geriatric Multimorbidity and Critical Care
  • Cardiometabolic Health & Lifestyle Factors
  • Pharmacological Interventions in Diabetes Management Through his research, he seeks to understand the intricate relationships between metabolic health, aging, and disease prevention.

Awards 🏆

Yang Li has received recognition for his significant contributions to medical research. His work has been acknowledged in the form of grants, academic awards, and invitations to present at international conferences. His research excellence continues to earn him accolades in the scientific community.

Publications 📚

Yang Li has authored multiple impactful publications in peer-reviewed journals. Some of his notable works include:

  • “Sex differences in associations of metabolic inflammation and insulin resistance with incident type 2 diabetes mellitus: a retrospective cohort of adults with annual health examinations”

    • Authors: Yang Li, Xiaotong Guo, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Huixiao Yuan, Shasha Geng, Yue Liu​

    • Publication Year: 2025​

  • “Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data”

    • Authors: Yang Li, Shasha Geng, Huixiao Yuan, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Yue Liu, Xiaotong Guo, Xiaoli Wang, et al.​

    • Publication Year: 2024​

  • “Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Yue Liu, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Huixiao Yuan, Xiaoli Wang, et al.​

    • Publication Date: November 16, 2024​

  • “Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis”

    • Authors: Qian Huang, Huixiao Yuan, Qingqing Li, Yang Li, Shasha Geng, Yingqian Zhu, Min Liao, Hua Jiang​

    • Publication Year: 2023​

  • “Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia”

    • Authors: Yingqian Zhu, Xin Chen, Shasha Geng, Qingqing Li, Yang Li, Huixiao Yuan, Hua Jiang​

    • Publication Year: 2023​

  • “Reliability of Risk Assessment for Intra-Hospital Venous Thromboembolism: An Exploratory Cross-Sectional Study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Xiaotong Guo, Yue Liu, Hua Jiang​

    • Publication Year: 2023​

  • “Lifestyle-based oxidative balance score and its association with cardiometabolic health of the community-dwelling elderly: A cross-sectional secondary analysis”

    • Authors: Yang Li, Huixiao Yuan, Qingqing Li, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: September 27, 2022​

  • “Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: December 2019​

  • “Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: July 11, 2019​

Conclusion 🏅

Yang Li is an accomplished medical researcher whose work contributes significantly to the field of internal medicine. His dedication to advancing medical knowledge, combined with his expertise in metabolic and geriatric health, underscores his role as a leading researcher in his field. Through his publications and ongoing research, he continues to impact patient care and medical science positively.

Haotai Xie | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Haotai Xie | Medicine | Best Researcher Award

Peking University First Hospital | China

Dr. Haotai Xie is a dedicated clinician and researcher at Peking University First Hospital, specializing in cardiovascular diseases and bioinformatics. With a passion for advancing precision cardiology, Dr. Xie integrates computational approaches into clinical practice, enhancing diagnostic accuracy and therapeutic strategies. His work spans biomarker discovery, algorithm development, and non-invasive myocardial ischemia evaluation. Dr. Xie has authored seven first-author SCI papers in high-impact journals, contributing significantly to cardiovascular medicine and epigenetics.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Academic Productivity: Published seven first-author SCI papers in prestigious journals like Nucleic Acids Research, Briefings in Bioinformatics, and JAHA, accumulating a total impact factor exceeding 40.
  • Innovative Research: Co-developed PhaSepDB and MloDisDB, which have become cornerstone resources in phase separation research, cited in over 50 studies.
  • Interdisciplinary Expertise: Bridges cardiovascular medicine and bioinformatics, applying computational methods to improve diagnostic tools and biomarker discovery, enhancing precision cardiology.
  • Significant Contributions: Pioneered the characterization of cardiovascular phenotypes in Kleefstra syndrome, leading to evidence-based screening protocols, with direct implications for clinical guidelines and rare disease management.
  • Research Impact: Work has advanced the understanding of cardiovascular epigenetics and contributed to earlier diagnosis and more personalized treatment strategies.

🎓 Education

  • Doctorate in Clinical Medicine, Peking University First Hospital, China.

💼 Experience

  • Doctor, Peking University First Hospital.
  • Lead researcher in interdisciplinary projects bridging computational biology and cardiovascular medicine.
  • Co-developed PhaSepDB and MloDisDB, pivotal resources for phase separation research.

🔬 Research Interests On Medicine

  • Cardiovascular Medicine
  • Bioinformatics
  • Precision Cardiology
  • Biomarker Discovery
  • AI-driven Diagnostic Tools

🏆 Awards

  • Recognized for sustained academic productivity and innovation in cardiovascular research.

📓 Publications

  • “Association between urinary sodium excretion and all-cause mortality: a cohort study in a Chinese community-based population”

    • Year: 2025
    • Authors: Haotai Xie, Xinyan Wen, Fangfang Fan, Jia Jia, Yong Huo, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (published recently)

  • “Highlighting cardiovascular manifestations of Kleefstra syndrome: literature review and clinical insights”

    • Year: 2025
    • Authors: Haotai Xie, Pengkang He, Qinhui Sheng, Wei Ma, Yanjun Gong, Yan Zhang, Lin Qiu
    • Citations: Not available yet (published recently)

  • “Rethinking the Functional SYNTAX Score Threshold”

    • Year: 2024
    • Authors: Haotai Xie
    • Citations: Not available yet (upcoming publication)

  • “Research Progress and Clinical Value of Subendocardial Viability Ratio”

    • Year: 2024
    • Authors: Haotai Xie, Lan Gao, Fangfang Fan, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (recent publication)

  • “PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information”

    • Year: 2023
    • Authors: Chao Hou, Xinxin Wang, Haotai Xie, Taoyu Chen, Peiyu Zhu, Xiaofeng Xu, Kaiqiang You, Tingting Li
    • Citations: Not specified

  • “Application of B-Type Natriuretic Peptide in Neonatal Diseases”

    • Year: 2021
    • Authors: Haotai Xie, Yixuan Huo, Qinzheng Chen, Xinlin Hou
    • Citations: Not specified

  • “MloDisDB: a manually curated database of the relations between membraneless organelles and diseases”

    • Year: 2021
    • Authors: Chao Hou, Haotai Xie, Yang Fu, Yao Ma, Tingting Li
    • Citations: Not specified

🔔 Conclusion

Dr. Haotai Xie exemplifies the fusion of clinical expertise and computational innovation, driving advancements in cardiovascular medicine. His research has not only deepened the understanding of cardiovascular diseases but also paved the way for precision cardiology. With a robust publication record and interdisciplinary approach, Dr. Xie continues to shape the future of cardiovascular health management through groundbreaking discoveries and technological integration.

Gregory Redding | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Gregory Redding | Medicine | Best Researcher Award

Professor of Pediatrics | University of Washington School of Medicine | United States

Dr. Gregory J. Redding, MD, is a distinguished pediatric pulmonologist known for his extensive contributions to pediatric respiratory medicine. Born on December 8, 1948, in Patuxent River, Maryland, he has dedicated his career to advancing pulmonary care, education, and research. With over four decades of experience, Dr. Redding has held prominent academic and clinical positions, shaping the field with his expertise and leadership. His dedication to patient care, innovative research, and mentorship has earned him numerous accolades throughout his career.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

✅ Extensive Experience: Dr. Redding has had a distinguished career spanning over four decades in pediatric pulmonology and sleep medicine, holding leadership roles at the University of Washington School of Medicine and Seattle Children’s Hospital.

✅ Research Contributions: His tenure includes multiple fellowships, faculty positions, and research leadership roles, with significant contributions to asthma, cystic fibrosis, and pediatric respiratory medicine.

✅ Recognition & Awards: He has been consistently recognized as a Top Doctor (2000-2025) and has received prestigious awards such as:

  • Lifetime Contributions to Pediatric Respiratory Medicine Award (2019, ATS)
  • Edwin L. Kendig, Jr Lifetime Achievement Award (2015, AAP)
  • Pulmonary Hall of Fame Award (2001, ALA of Washington)

✅ Leadership & Professional Impact: He has chaired or served on numerous committees in national and international respiratory and pediatric societies, influencing clinical practice and policy development.

🎓 Education:

Dr. Redding’s academic journey began with a Bachelor of Arts (B.A.) from the University of California, San Diego, in 1970. He then pursued his Doctor of Medicine (M.D.) degree at Stanford University School of Medicine, graduating in 1974. Following medical school, he completed an internship (1974-75) and pediatric residency (1975-77) at Harbor General Hospital in Torrance, California. Further specializing in pediatric pulmonology, he underwent fellowship training at the University of Colorado Medical Center from 1977 to 1979, followed by a postdoctoral research fellowship in the Cardiovascular Pulmonary Research Laboratory (1979-80).

💼 Experience:

Dr. Redding has had a prolific career in both academia and clinical practice. He has been a faculty member at the University of Washington School of Medicine since 1980, progressing through the ranks from Assistant Professor to full Professor in the Department of Pediatrics. His leadership roles at Seattle Children’s Hospital have been pivotal, where he served as Chief of the Pulmonary and Sleep Medicine Division (2010-2023) and Chief of the Pediatric Pulmonary Division (1980-2010). In addition, he has held consulting medical staff positions at renowned institutions, including Seattle Cancer Care Alliance, Alaska Native Medical Center, and Harborview Medical Center.

🔬 Research Interests On Medicine

Dr. Redding’s research focuses on pediatric respiratory disorders, including cystic fibrosis, asthma, and pulmonary function in children with craniofacial anomalies. He has been actively involved in clinical and translational research, contributing to the advancement of pediatric pulmonology through his investigations into airway inflammation, bronchiolitis management, and the long-term effects of respiratory conditions. His commitment to improving pediatric respiratory care has led to influential studies and practice-changing guidelines.

🏆 Awards & Honors:

Throughout his career, Dr. Redding has received numerous prestigious awards recognizing his contributions to pediatric pulmonology. He has been consistently listed among America’s Top Doctors (2001-2023) and Seattle’s Top Doctors (2002-2025). Notable accolades include the American Thoracic Society Assembly on Pediatrics Lifetime Contributions to Pediatric Respiratory Medicine Award (2019), the Edwin L. Kendig, Jr. Lifetime Achievement Award for Pediatric Pulmonology (2015), and the Robert M. Campbell, Jr. Award for Innovation in Early Onset Scoliosis (2018). His commitment to teaching has been recognized with multiple Pediatric Housestaff Awards for Outstanding Teaching at Seattle Children’s Hospital.

📚 Publications:

Dr. Redding has authored numerous peer-reviewed publications in leading medical journals. His research has been widely cited, influencing clinical practice and pediatric pulmonology guidelines. Some of his key publications include:

  • “Changes in Diaphragm Intrusion and Thoracic Dimensions After Posterior Spinal Fusion in Patients With Neuromuscular Scoliosis”

    • Authors: G.A. Benes, Gregory A.; P.G. Gabos, Peter G.; G.J. Redding, Gregory J.; P.J. Cahill, Patrick J.; P.D. Sponseller, Paul David
    • Publication Year: 2025

  • “Posterior Column Release and Lengthening with a Magnetic Growing Rod Construct in Severe Congenital Thoracic Fusion: A Report of 2 Cases”

    • Authors: M. Trask, Michael; J.T. Yamaguchi, Jonathan Tad; G.J. Redding, Gregory J.; S.R. Browd, Samuel R.; K.K. White, Klane K.
    • Publication Year: 2024

  • “In-office Maximal Voluntary Ventilation Testing Demonstrates Pulmonary Improvement Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis”

    • Authors: H.B. Jalloh, Hulaimatu B.; L.M. Andras, Lindsay M.; G.J. Redding, Gregory J.; J. Yang, Joshua; D.L. Skaggs, David L.
    • Publication Year: 2024

  • “Elevated Periodic Limb Movement Index is Associated with Hypoxemia in Children with Early Onset Scoliosis”

    • Authors: L.M. DelRosso, Lourdes M.; D. Panek, David; E.W. MacKintosh, Erin Walker; K.K. White, Klane K.; G.J. Redding, Gregory J.
    • Publication Year: 2024

  • “Pre-op Considerations in Neuromuscular Scoliosis Deformity Surgery: Proceedings of the Half Day Course at the 58th Annual Meeting of the Scoliosis Research Society”

    • Authors: M.C. Welborn, Michelle Cameron; G.J. Redding, Gregory J.; P.D. Evers, Patrick D.; S.C. Poon, Selina C.; S.W. Hwang, Steven W.
    • Publication Year: 2024

  • “Chronic Respiratory Disease in Indigenous Peoples: A Framework to Address Inequity and Strengthen Respiratory Health and Health Care Globally”

    • Authors: A.B. Chang, Anne B.; T.A. Kovesi, Thomas Andrew; G.J. Redding, Gregory J.; P.J. Torzillo, Paul John; D.M. Gray, Diane M.
    • Publication Year: 2024
    • Citations: 8

  • “Paediatric Syndromic Scoliosis: Proceedings of the Half-Day Course at the 57th Annual Meeting of the Scoliosis Research Society”

    • Authors: J.S. Mehta, Jwalant S.; J.M. Pahys, Joshua M.; A.I. Saad, Ahmed Isam; M.C. Welborn, Michelle Cameron; G.J. Redding, Gregory J.
    • Publication Year: 2024
    • Citations: 2

  • “Social Determinants of Respiratory Health from Birth: Still of Concern in the 21st Century?”

    • Authors: A.P. Bush, Andrew P.; C.A. Byrnes, C. A.; K.C.C. Chan, Kate Ching Ching; I.P. Sinha, Ian P.; H.J. Zar, Heather J.
    • Publication Year: 2024
    • Citations: 8

  • “Chest and Spinal Disease in Patients with Progressive Neuromuscular Disease”

    • Authors: O.H. Mayer, Oscar Henry; G.J. Redding, Gregory J.
    • Publication Year: 2024
    • Citations: 0

  • “Preoperative Left Shoulder Elevation > 1 cm is Predictive of Severe Postoperative Shoulder Imbalance in Early Onset Idiopathic Scoliosis Patients Treated with Growth-Friendly Instrumentation”

    • Authors: Y. Li, Ying; D.Z. Yang, Daniel Z.; R. Bergman, Rachel; Y. Li, Ying; C.R. Louer, Craig R.
    • Publication Year: 2023
    • Citations: 1

🔚 Conclusion:

Dr. Gregory J. Redding, MD, stands as a pillar in pediatric pulmonology, contributing significantly to patient care, research, and medical education. His lifelong commitment to improving respiratory health in children has left a lasting impact on the field. Through his academic leadership, clinical expertise, and dedication to mentoring the next generation of pediatric pulmonologists, Dr. Redding continues to shape the future of pediatric respiratory medicine. His work remains a testament to excellence in medicine, research, and advocacy for pediatric respiratory health.